Joel R Perloff, MD | |
2112 Providence Ave, Chester, PA 19013-5507 | |
(610) 874-5366 | |
(610) 874-8448 |
Full Name | Joel R Perloff |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 25 Years |
Location | 2112 Providence Ave, Chester, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205917820 | NPI | - | NPPES |
2281172000 | Other | PA | IBC HMO |
1602669 | Other | PA | IBC PPO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | MD417931 (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Crozer Chester Medical Center | Upland, PA | Hospital |
Riddle Memorial Hospital | Media, PA | Hospital |
Main Line Hospital Lankenau | Wynnewood, PA | Hospital |
Delaware County Memorial Hospital | Drexel hill, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Providence Ear Nose And Throat Associates Inc | 1456349497 | 11 |
News Archive
Information on the internet about the health risks associated with the consumption of smokeless tobacco usually overstates the risk. This is the conclusion of research published today in the Open Access journal BMC Public Health, entitled "You might as well smoke; the misleading and harmful public message about smokeless tobacco".
Because billions of neurons are packed into our brain, the neuronal circuits that are responsible for controlling our behaviors are by necessity highly intermingled. This tangled web makes it complicated for scientists to determine exactly which circuits do what. Now, using two laboratory techniques pioneered in part at Caltech, Caltech researchers have mapped out the pathways of a set of neurons responsible for the kinds of motor impairments-such as difficulty walking-found in patients with Parkinson's disease.
A world-wide competition to bring emerging breast cancer technologies to market is being launched by the Avon Foundation for Women, in partnership with the National Cancer Institute (NCI), part of the NIH, and the Center for Advancing Innovation.
Researchers centered at Nagoya University develop a nanowire device able to detect microscopic levels of urinary markers potentially implicated in cancer.
Cancer researchers are turning to mathematical models to help answer important clinical questions, and a new paper in Cancer Research, a journal of the American Association for Cancer Research, illustrates how the technique may answer questions about Herceptin resistance.
› Verified 9 days ago
Entity Name | Providence Ear Nose & Throat Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366523904 PECOS PAC ID: 1456349497 Enrollment ID: O20040506000238 |
News Archive
Information on the internet about the health risks associated with the consumption of smokeless tobacco usually overstates the risk. This is the conclusion of research published today in the Open Access journal BMC Public Health, entitled "You might as well smoke; the misleading and harmful public message about smokeless tobacco".
Because billions of neurons are packed into our brain, the neuronal circuits that are responsible for controlling our behaviors are by necessity highly intermingled. This tangled web makes it complicated for scientists to determine exactly which circuits do what. Now, using two laboratory techniques pioneered in part at Caltech, Caltech researchers have mapped out the pathways of a set of neurons responsible for the kinds of motor impairments-such as difficulty walking-found in patients with Parkinson's disease.
A world-wide competition to bring emerging breast cancer technologies to market is being launched by the Avon Foundation for Women, in partnership with the National Cancer Institute (NCI), part of the NIH, and the Center for Advancing Innovation.
Researchers centered at Nagoya University develop a nanowire device able to detect microscopic levels of urinary markers potentially implicated in cancer.
Cancer researchers are turning to mathematical models to help answer important clinical questions, and a new paper in Cancer Research, a journal of the American Association for Cancer Research, illustrates how the technique may answer questions about Herceptin resistance.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Joel R Perloff, MD 2112 Providence Ave, Chester, PA 19013 Ph: (610) 874-5366 | Joel R Perloff, MD 2112 Providence Ave, Chester, PA 19013-5507 Ph: (610) 874-5366 |
News Archive
Information on the internet about the health risks associated with the consumption of smokeless tobacco usually overstates the risk. This is the conclusion of research published today in the Open Access journal BMC Public Health, entitled "You might as well smoke; the misleading and harmful public message about smokeless tobacco".
Because billions of neurons are packed into our brain, the neuronal circuits that are responsible for controlling our behaviors are by necessity highly intermingled. This tangled web makes it complicated for scientists to determine exactly which circuits do what. Now, using two laboratory techniques pioneered in part at Caltech, Caltech researchers have mapped out the pathways of a set of neurons responsible for the kinds of motor impairments-such as difficulty walking-found in patients with Parkinson's disease.
A world-wide competition to bring emerging breast cancer technologies to market is being launched by the Avon Foundation for Women, in partnership with the National Cancer Institute (NCI), part of the NIH, and the Center for Advancing Innovation.
Researchers centered at Nagoya University develop a nanowire device able to detect microscopic levels of urinary markers potentially implicated in cancer.
Cancer researchers are turning to mathematical models to help answer important clinical questions, and a new paper in Cancer Research, a journal of the American Association for Cancer Research, illustrates how the technique may answer questions about Herceptin resistance.
› Verified 9 days ago
Dr. Kelli Ann Quercetti, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2112 Providence Ave, Chester, PA 19013 Phone: 610-874-5366 Fax: 610-874-8448 | |
Mark A. Ginsburg, DO Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2112 Providence Ave, Chester, PA 19013 Phone: 610-874-5366 Fax: 610-874-8448 | |
John M Feehery, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2112 Providence Ave, Chester, PA 19013 Phone: 610-874-5366 Fax: 610-874-8448 | |
William S Gartner Jr., MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2112 Providence Ave, Chester, PA 19013 Phone: 610-874-5366 Fax: 610-874-8448 | |
Dr. Kenneth B. Briskin, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2112 Providence Avenue, Chester, PA 19013 Phone: 610-874-5366 Fax: 610-874-8448 | |
Dr. Steven W. Fischer, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2112 Providence Ave, Chester, PA 19013 Phone: 610-874-5366 Fax: 610-874-8448 |